Sugi Predict

Sugi Predict / Compounds / SCHEMBL323801

SCHEMBL323801

SCHEMBL323801

COc1ccccc1OCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 1.00
▸ SMN1; SMN2 Q16637 2/20 1.00
▸ L3MBTL1 Q9Y468 2/20 0.72
▸ GLA P06280 1/20 0.72
▸ LMNA P02545 1/20 0.68
▸ HSD17B10 Q99714 2/20 0.64
▸ HPGD P15428 2/20 0.58
▸ PTGDR2 Q9Y5Y4 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ MEN1 O00255 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ RXRA P19793 1/20 0.56
▸ MAPT P10636 1/20 0.55
▸ ALOX15 P16050 1/20 0.55
▸ ATM Q13315 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL27939411 0.98 POLB (0.96) POLBSMN1; SMN2L3MBTL1GLALMNA
SCHEMBL9855264 0.90 POLB (0.81) POLBSMN1; SMN2L3MBTL1GLALMNA
SCHEMBL29682135 0.89 L3MBTL1 (0.80) POLBSMN1; SMN2L3MBTL1GLAHSD17B10
SCHEMBL340762 0.89 L3MBTL1 (0.80) POLBSMN1; SMN2L3MBTL1GLAHSD17B10
Ammonia Solution, Strong SCHEMBL28240461 0.87 L3MBTL1 (0.77) POLBSMN1; SMN2L3MBTL1GLAHSD17B10
SCHEMBL10509566 0.86 SMN1; SMN2 (0.75) POLBSMN1; SMN2L3MBTL1GLALMNA
SCHEMBL5181008 0.84 L3MBTL1 (1.00) POLBSMN1; SMN2L3MBTL1GLAHPGD
SCHEMBL5520675 0.84 SMN1; SMN2 (0.72) POLBSMN1; SMN2LMNAHSD17B10HPGD
SCHEMBL2559539 0.84 L3MBTL1 (0.72) POLBSMN1; SMN2L3MBTL1GLALMNA
SCHEMBL7406459 0.84 SMN1; SMN2 (0.72) POLBSMN1; SMN2L3MBTL1GLALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118184679-A Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material 中国石油天然气股份有限公司 2024-06-14 — — CN claimed
EP-1556227-A1 HETERO-SUBSTITUTED ARYL ACETIC ACID CO-INITIATORS FOR IR-SENSITIVE COMPOSITIONS Kodak Polychrome Graphics LLC (US) 2005-07-27 — — EP claimed
WO-2004041544-A1 HETERO-SUBSTITUTED ARYL ACETIC ACID CO-INITIATORS FOR IR-SENSITIVE COMPOSITIONS KODAK POLYCHROME GRAPHICS LLC (US) 2004-05-21 — — WO claimed
US-20040091811-A1 Hetero-substituted aryl acetic acid co-initiators for IR-sensitive compositions KODAK POLYCHROME GRAPHICS, LLC 2004-05-13 — — US claimed
EP-0021177-B1 MAYTANSINOIDS, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1984-02-08 — — EP claimed
EP-0014651-B1 TALAMPICILLIN 2-METHOXYPHENOXY ACETATE, PROCESS FOR ITS PREPARATION AND MEDICAMENTS CONTAINING IT SANOFI S.A. (FR) 1982-08-04 — — EP claimed
US-4293560-A BACTERICIDES, ANTIBIOTICS C M INDUSTRIES (FR) 1981-10-06 — — US claimed
EP-0014651-A1 Talampicillin 2-methoxyphenoxy acetate, process for its preparation and medicaments containing it SANOFI S.A. (FR) 1980-08-20 — — EP claimed
US-20250388604-A1 Compounds and Their Use as PDE4 Activators MIRONID LIMITED (GB) 2025-12-25 — — US disclosed
EP-4572762-A1 COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS Mironid Limited (GB) 2025-06-25 — — EP disclosed
WO-2024143473-A1 DECOMPOSITION INHIBITOR FOR TRANSITION METAL OXIDANTS 株式会社トクヤマ 2024-07-04 — — WO disclosed
CN-118184679-A Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material 中国石油天然气股份有限公司 2024-06-14 — — CN disclosed
WO-2024038128-A1 COMPOUNDS AND THEIR USE AS PDE4 ACTIVATORS MIRONID LIMITED (GB) 2024-02-22 — — WO disclosed
US-20230200386-A1 MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS HERBICIDES IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. 2023-06-29 — — US disclosed
EP-0014651-A1 Talampicillin 2-methoxyphenoxy acetate, process for its preparation and medicaments containing it SANOFI S.A. (FR) 1980-08-20 — — EP disclosed
EP-0014651-A1 Talampicillin 2-methoxyphenoxy acetate, process for its preparation and medicaments containing it SANOFI S.A. (FR) 1980-08-20 — — EP disclosed
EP-0014651-A1 Talampicillin 2-methoxyphenoxy acetate, process for its preparation and medicaments containing it SANOFI S.A. (FR) 1980-08-20 — — EP disclosed
US-4086240-A 1-Thiazolyl-5-phenoxy and phenylthioalkanoyloxyimidazolidinones VELSICOL CHEMICAL CORPORATION (US) 1978-04-25 — — US disclosed
US-4053480-A 1-THIADIAZOLYL-5-PHENOXY- AND PHENYLTHIOALKANOYLOXY IMIDAZOLIDINONES VELSICOL CHEMICAL CORPORATION (US) 1977-10-11 — — US disclosed
US-3985559-A Toner powder for electrostatic images OCE-VAN DER GRINTEN N.V. (NL) 1976-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230200386-A1 MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS HERBICIDES DDT, CYP4B1, GSTO1 POLB 4046/4885SMN1; SMN2 3236/4885L3MBTL1 1489/4885
US-20250388604-A1 Compounds and Their Use as PDE4 Activators PDE4A, PDE7A, PDE4B POLB 773/4885SMN1; SMN2 1015/4885L3MBTL1 3716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.